Lokacin da aka saba amfani da shi wajen hada jini a jikin dan adam ya bambanta dangane da hanyar gano cutar.
Ga wasu hanyoyi da dama na gano abubuwa da kuma hanyoyin da suka dace da su:
1 Lokacin thromboplastin na ɗan lokaci (APTT):
Matsakaicin ma'aunin da aka saba amfani da shi yawanci daƙiƙa 25-37 ne. APTT galibi yana nuna aikin abubuwan haɗin jini VIII, IX, XI, XII, da sauransu a cikin hanyar haɗin jini ta ciki.
Lokacin Prothrombin 2 (PT):
Matsakaicin ƙimar ma'auni yawanci shine daƙiƙa 11-13. Ana amfani da PT galibi don tantance aikin abubuwan haɗin jini na II, V, VII, X, da sauransu a cikin hanyar haɗin jini na waje.
Rabon da aka daidaita na ƙasa da ƙasa 3 (INR):
Matsakaicin ma'aunin da aka saba amfani da shi yana tsakanin 0.8 da 1.2. Ana ƙididdige INR bisa ga ƙimar PT kuma ana amfani da shi don sa ido kan tasirin maganin hana zubar jini na baki (kamar warfarin) don sa sakamakon gwajin tsakanin dakunan gwaje-gwaje daban-daban su yi kama da juna.
4 Fibrinogen (FIB):
Matsakaicin ma'aunin da aka saba amfani da shi shine 2-4g/L. FIB wani glycoprotein ne na jini wanda hanta ta samar kuma yana taka muhimmiyar rawa a cikin tsarin hada jini. Ana canza shi zuwa fibrin a ƙarƙashin aikin thrombin don samar da gudan jini.
Ya kamata a lura cewa kayan aikin gwaji da reagents na dakunan gwaje-gwaje daban-daban na iya bambanta, kuma takamaiman ƙimar tunani na yau da kullun na iya ɗan bambanta. Bugu da ƙari, wasu abubuwan ilimin halittar jiki (kamar shekaru, jinsi, ciki, da sauransu) da abubuwan da ke haifar da cututtuka (kamar cututtukan hanta, cututtukan tsarin jini, shan wasu magunguna, da sauransu) suma za su shafi lokacin coagulation. Saboda haka, lokacin fassara sakamakon lokacin coagulation, yana buƙatar yin cikakken bincike tare da takamaiman yanayin majiyyaci.
Kamfanin FASAHA NA BEIJING INC.
GYARAN HADA HADIN AYYUKAN MAI TARIN HADAWA
APPLICATION NA ANALYZER REAGENS
Kamfanin Beijing Succeeder Technology Inc. (lambar hannun jari: 688338) ya daɗe yana aiki a fannin gano cutar coagulation tun lokacin da aka kafa shi a shekarar 2003, kuma ya kuduri aniyar zama jagora a wannan fanni. Kamfanin da ke hedikwata a Beijing, yana da ƙungiyar bincike da ci gaba, samarwa da tallace-tallace masu ƙarfi, suna mai da hankali kan ƙirƙira da amfani da fasahar gano cutar thrombosis da hemostasis.
Tare da ƙarfin fasaha mai ban mamaki, Succeeder ya lashe haƙƙin mallaka guda 45 da aka amince da su, waɗanda suka haɗa da haƙƙin mallaka guda 14 na ƙirƙira, haƙƙin mallaka guda 16 na samfuran amfani da haƙƙin mallaka guda 15. Kamfanin yana kuma da takaddun shaidar rajistar samfuran na'urorin likitanci guda 32 na Aji II, takaddun shaida na shigarwa na Aji I guda 3, da kuma takardar shaidar CE ta EU ga samfura 14, kuma ya wuce takardar shaidar tsarin kula da inganci na ISO 13485 don tabbatar da inganci da kwanciyar hankali na ingancin samfura.
Succeeder ba wai kawai wani muhimmin kamfani ne na Shirin Ci Gaban Masana'antar Magungunan Halittu na Beijing (G20) ba, har ma ya samu nasarar shiga Hukumar Kirkire-kirkire ta Kimiyya da Fasaha a shekarar 2020, wanda hakan ya kai ga ci gaban kamfanin. A halin yanzu, kamfanin ya gina hanyar sadarwa ta tallace-tallace a duk fadin kasar da ta shafi daruruwan wakilai da ofisoshi. Ana sayar da kayayyakinsa sosai a mafi yawan sassan kasar. Haka kuma yana fadada kasuwannin kasashen waje tare da ci gaba da inganta gasa a duniya.
Katin kasuwanci
WeChat na kasar Sin